Intravenous immunoglobulin preparation prevents the production of pro-inflammatory cytokines by modulating NFκB and MAPKs pathways in the human monocytic THP-1 cells stimulated with procalcitonin

Intravenous immunoglobulin preparation attenuates LPS-induced production of pro-inflammatory cytokines in human monocytic cells by modulating TLR4-mediated signaling pathways

(2013) Kazuki Murakami et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Procalcitonin and the role of biomarkers in the diagnosis and management of sepsis

(2012) Stefan Riedel   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Intravenous immunoglobulin prevents release of proinflammatory cytokines in human monocytic cells stimulated with procalcitonin

(2012) Kazuki Murakami et al.   INFLAMMATION RESEARCH

Immune regulation of procalcitonin: a biomarker and mediator of infection

(2012) G. N. Matwiyoff et al.   INFLAMMATION RESEARCH

Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future

(2011) Philipp Schuetz et al.   BMC Medicine

In vitro inhibition of tumour necrosis factor-α and interleukin-6 production by intravenous immunoglobulins

(2010) Michel Toungouz et al.   BRITISH JOURNAL OF HAEMATOLOGY

The IgG molecule as a biological immune response modifier: Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders

(2010) Mark Ballow   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target

(2009) Kenneth L. Becker et al.   BRITISH JOURNAL OF PHARMACOLOGY

Analyzing real-time PCR data by the comparative CT method

(2008) Thomas D Schmittgen et al.   Nature Protocols